(Q28218131)

0 references

Hua Gao

0 references

Yanxiang Ni

0 references

Beibei Wang

0 references

Yalan Wu

0 references

Lili Ji

0 references

Linhua Qin

0 references

Lan Ma

0 references

Gang Pei

Journal of Biological Chemistry

0 references

language of work or name

English

0 references

publication date

21 February 2003

0 references

published in

0 references

volume

278

0 references

issue

0 references

page(s)

6363-70

0 references

cites work

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Regulation of p53 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

MDM2--master regulator of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

21 January 2018

MDM2: life without p53.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

The MDM2 RING-finger domain is required to promote p53 nuclear export

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Nucleolar Arf sequesters Mdm2 and activates p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Signal transduction by the JNK group of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

A molecular pathway for light-dependent photoreceptor apoptosis in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

The formation of stable rhodopsin-arrestin complexes induces apoptosis and photoreceptor cell degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

beta-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between beta-arrestin and CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Suppression of ultraviolet irradiation-induced apoptosis by overexpression of focal adhesion kinase in Madin-Darby canine kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Involvement of the acid sphingomyelinase pathway in uva-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Direct binding of beta-arrestins to two distinct intracellular domains of the delta opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Regulation of p53 stability by Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

MDMX inhibits the p300/CBP-mediated acetylation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

beta-Arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

Muscarinic receptors mediate phospholipase C-dependent activation of protein kinase B via Ca2+, ErbB3, and phosphoinositide 3-kinase in 1321N1 astrocytoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M210350200

21 January 2018

Identifiers

DOI

10.1074/JBC.M210350200

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

12488444

1 reference

Consolidated OpenCitations Corpus – April 2017